PAUL BENITES: Open Payments
NPI 1821190778 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,454 in 167 payments from 19 companies in 2025. Trend: 2023 $7,416 · 2024 $4,318 · 2025 $4,454
Food & beverage: $4,374Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $1,007 |
| PFIZER INC. | 15 | $507 |
| UCB, Inc. | 19 | $494 |
| Regeneron Healthcare Solutions, Inc. | 15 | $459 |
| LEO Pharma Inc. | 11 | $255 |
| GENZYME CORPORATION | 8 | $242 |
| E.R. Squibb & Sons, L.L.C. | 13 | $222 |
| Organon LLC | 4 | $192 |
| Amgen Inc. | 7 | $188 |
| Incyte Corporation | 8 | $166 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, RINVOQ, CIBINQO, ADBRY, LITFULO, Sotyktu.
Industry payments across NY — which companies pay providers there.
